Markets

Supernus Pharmaceuticals (SUPN) Jumps: Stock Rises 6.2%

Supernus Pharmaceuticals, Inc.SUPN was a big mover last session, as its shares rose over 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up roughly 12% in the past one-month time frame.

Over the last 30 days, the company witnessed two positive and four negative estimate revisions while the Zacks Consensus Estimate also moved lower over the same time frame, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent move higher can last.

Supernus Pharmaceuticals currently carries a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Supernus Pharmaceuticals, Inc. Price

Supernus Pharmaceuticals, Inc. Price | Supernus Pharmaceuticals, Inc. Quote

A better-ranked stock in the Medical - Generic Drugs space is Aquinox Pharmaceuticals, Inc. AQXP , carrying a Zacks Rank #2 (Buy). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

Is SUPN going up? Or down? Predict to see what others think: Up or Down

Will You Make a Fortune on the Shift to Electric Cars?

Here's another stock idea to consider. Much like petroleum 150 years ago, lithium power may soon shake the world, creating millionaires and reshaping geo-politics. Soon electric vehicles (EVs) may be cheaper than gas guzzlers. Some are already reaching 265 miles on a single charge.

With battery prices plummeting and charging stations set to multiply, one company stands out as the #1 stock to buy according to Zacks research.

It's not the one you think.

See This Ticker Free >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Aquinox Pharmaceuticals, Inc. (AQXP): Free Stock Analysis Report

Supernus Pharmaceuticals, Inc. (SUPN): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

SUPN NLTX

Other Topics

Investing Stocks